What Does Taysha Gene Therapies Do?

Total employees96
HeadquartersDallas
Founded2020

Taysha Gene Therapies is a patient-centric, clinical-stage gene therapy company dedicated to discovering, developing, and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system (CNS). Their approach targets both rare and large patient populations, aiming to provide transformative treatments for severe neurological disorders. The company leverages its deep expertise in gene therapy and CNS diseases to advance a pipeline of innovative candidates.

Where Is Taysha Gene Therapies's Headquarters?

Taysha Gene Therapies officeTaysha Gene Therapies officeTaysha Gene Therapies officeTaysha Gene Therapies office
*Images sourced via web search. Rights belong to original owners

HQ Function

Serves as the corporate headquarters, overseeing strategic direction, clinical development, financial operations, investor relations, and administrative functions.

Notable Features:

Located in a modern office complex in North Dallas, providing a professional environment designed to support collaboration and innovation.

Work Culture:

Taysha fosters a science-driven, agile, and patient-focused work environment. The culture emphasizes collaboration, urgency in addressing unmet medical needs, and a commitment to scientific excellence and integrity.

HQ Significance:

The Dallas headquarters centralizes Taysha's core leadership and operational decision-making, enabling efficient management of its clinical programs and corporate strategy. Its location provides access to a skilled talent pool and business infrastructure.

Values Reflected in HQ: The headquarters' setup reflects Taysha's commitment to professionalism, operational efficiency, and providing a conducive environment for its team to advance its mission.

Location:

Taysha Gene Therapies is primarily focused on developing therapies with regulatory strategies targeting major markets like the United States and Europe. Their clinical trials often involve international sites to ensure diverse patient participation. The company actively engages with global patient advocacy groups, researchers, and key opinion leaders to inform and advance its development programs for CNS disorders with worldwide impact.

Street Address:

17877 North Dallas Parkway, Suite 200

City:

Dallas

State/Province:

Texas

Country:

USA

Where Else Does Taysha Gene Therapies Operate Around the World?

Durham, North Carolina, USA

Address: Research and Development Facility in Durham (Specific current address for the downsized R&D space not publicly detailed, located in the Research Triangle Park area)

Strategically located in the Research Triangle Park (RTP) area, a prominent global hub for biomedical research, offering access to specialized talent, collaborators, and research infrastructure.

Buying Intent Signals for Taysha Gene Therapies

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Taysha Gene Therapies? Meet the Executive Team

As of April 2025, Taysha Gene Therapies' leadership includes:

Sean P. Nolan - Chairman and Chief Executive Officer
Sukumar (Suku) Nagendran, M.D. - President, Head of R&D
Kamran Alam - Chief Financial Officer
Mary Newman - Chief Operating Officer
Ernesto Aycardi, M.D. - Chief Medical Officer

Who's Investing in Taysha Gene Therapies?

Taysha Gene Therapies has been backed by several prominent investors over the years, including:

PBM Capital Group
RA Capital Management, L.P.
FMR LLC (Fidelity Management & Research)
BlackRock, Inc.
The Vanguard Group, Inc.

What Leadership Changes Has Taysha Gene Therapies Seen Recently?

Hire3
Exits2

Taysha Gene Therapies has experienced significant leadership updates over the past 12 months, including the appointment of a new CEO, CFO, and COO, reflecting strategic shifts and a focus on advancing its clinical pipeline.

Departures

RA Session II, RA Session II stepped down from his leadership roles at Taysha Gene Therapies.
Tiffany Olson, Tiffany Olson concluded her tenure as Chief Financial Officer.

New Appointments:

Sean P. Nolan, Sean P. Nolan transitioned from Chairman to Chief Executive Officer, taking lead of the company's strategic direction.
Kamran Alam, Kamran Alam joined Taysha Gene Therapies as Chief Financial Officer.
Mary Newman, Mary Newman joined Taysha Gene Therapies as Chief Operating Officer.

What Technology (Tech Stack) Is Used byTaysha Gene Therapies?

Discover the tools Taysha Gene Therapies uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Taysha Gene Therapies Email Formats and Examples

Taysha Gene Therapies typically uses a standard professional email format. The most common structure observed is the first initial of the employee's first name followed by their full last name.

[first_initial][last]@tayshagtx.com

Format

snolan@tayshagtx.com

Example

85%

Success rate

What's the Latest News About Taysha Gene Therapies?

GlobeNewswire • May 13, 2024

Taysha Gene Therapies Appoints Kamran Alam as Chief Financial Officer and Mary Newman as Chief Operating Officer

Taysha Gene Therapies announced the appointments of Kamran Alam as Chief Financial Officer and Mary Newman as Chief Operating Officer, strengthening its executive leadership team....more

GlobeNewswire • May 13, 2024

Taysha Gene Therapies Reports First Quarter 2024 Financial Results and Provides Corporate Update

Taysha reported its financial results for the first quarter of 2024 and provided updates on its clinical programs, including progress on TSHA-102 for Rett syndrome and TSHA-120 for GAN....more

GlobeNewswire • April 18, 2024

Taysha Gene Therapies Announces Positive Long-Term Follow-Up Data from Low-Dose Cohort and Initial Data from High-Dose Cohort of the REVEAL Phase 1/2 Adolescent and Adult Trial of TSHA-102 in Rett Syndrome

Taysha announced promising clinical data for TSHA-102 in treating Rett syndrome, showing sustained improvements in the low-dose cohort and encouraging initial results from the high-dose cohort....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Taysha Gene Therapies, are just a search away.